Zoomcar (ZCAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Mar, 2026Executive summary
Annual Meeting scheduled for March 27, 2026, to be held virtually, with record date set as February 27, 2026.
Board unanimously recommends voting in favor of all proposals, which include director re-election, auditor ratification, capital structure changes, and equity issuances.
Voting can be conducted online, by phone, mail, or during the virtual meeting, with detailed instructions provided.
Proxy materials include comprehensive information on proposals, governance, compensation, and related party transactions.
Voting matters and shareholder proposals
Ratification of Bansal & Co LLP as independent auditor for fiscal year ending March 31, 2026.
Re-election of Mohan Ananda as Class II director for a three-year term expiring at the 2029 Annual Meeting.
Amendment to increase authorized shares of Common Stock from 260,000,000 to 2,000,000,000.
Approval of private placement offering up to $5,000,000 in units to accredited investors.
Approval of issuance of up to 490,412,089 shares in exchange for outstanding warrants (first tender offer).
Approval of issuance of up to 18,780,000 shares in exchange for additional outstanding warrants (second tender offer).
Approval of 1,000,000 restricted shares to Uri Levine, Chairman, as an inducement grant.
Approval to adjourn the meeting if necessary to solicit more votes.
Board of directors and corporate governance
Board consists of five members divided into three classes, with staggered three-year terms.
Standing committees include Audit, Compensation, and Nominating and Corporate Governance, all with independent directors.
Audit Committee chaired by Evelyn D'An, who is also the audit committee financial expert.
Code of ethics and insider trading policies are in place; compensation clawback policy adopted in December 2023.
Latest events from Zoomcar
- Record contribution profit and sharply reduced net loss, but severe liquidity risks persist.ZCAR
Q3 25/2627 Feb 2026 - Contribution profit and margins improved, but severe liquidity and debt issues threaten viability.ZCAR
Q1 25/2616 Feb 2026 - Record contribution margin and bookings growth, but urgent capital needs persist.ZCAR
Q3 24/2524 Dec 2025 - Shareholders to vote on private placements, equity plan changes, and a reverse stock split.ZCAR
Proxy Filing2 Dec 2025 - Key votes include director elections, a reverse split, Bridge Warrants, and auditor ratification.ZCAR
Proxy Filing2 Dec 2025 - Annual meeting seeks approval for director elections, reverse split, Bridge Warrants, and auditor ratification.ZCAR
Proxy Filing2 Dec 2025 - Votes sought on large private placements, equity plan expansion, and consultant share issuance.ZCAR
Proxy Filing2 Dec 2025 - Key votes include director elections, a reverse split, warrant exercise, and auditor ratification.ZCAR
Proxy Filing2 Dec 2025 - Shareholders will vote on private placements, equity plan changes, and a reverse stock split.ZCAR
Proxy Filing2 Dec 2025